IRON - NASDAQ

Disc Medicine, Inc.

IRON·NASDAQ

$70.35

-2.3%

HealthcareBiotechnology

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$2.69B

EPS-6.0100

P/E Ratio-11.71

Earnings Date08/06/2026

806.88M

Assets

62%

3Y+303.0%

5Y+9599.0%

10Y+9599.0%

67.05M

Total Liabilities

26%

3Y+184.0%

5Y+122.0%

10Y+122.0%

739.83M

Total Equity

67%

3Y+319.0%

5Y-3484.0%

10Y-3484.0%

Disc Medicine, Inc. Funding & Solvency Profile

IRON · NASDAQ

Current Assets

Cash & Cash Equivalents91.14M

Net Receivables0.00

Inventory0.00

Other Current Assets12.75M

Total Current Assets804 M

Non-Current Assets

Property, Plant & Equipment2.25M

Goodwill & Intangible Assets0.00

Long-Term Investments0.00

Other Non-Current Assets726.00K

Total Non-Current Assets3 M

Total Assets

806.88M

Financial Health Analysis

Current Ratio

21.94x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.09x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

767 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

100% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Disc Medicine, Inc. Balance Sheet

IRON • NASDAQ

Disc Medicine, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	91.1M	192.4M	360.4M	194.6M	88M	4.5M
Short-Term Investments	700M	297.4M	0.0	0.0	0.0	0.0
Cash & Short-Term Investments	791.2M	489.9M	360.4M	194.6M	88M	4.5M
Prepaids	0.0	0.0	5.3M	3.9M	3.3M	562K
Other Current Assets	12.7M	3.7M	0.0	0.0	-802K	0.0
Total Current Assets	803.9M	493.6M	365.7M	198.5M	90.5M	5.1M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	2.3M	2.3M	2.1M	1.6M	1.7M	294K
Other Non-Current Assets	726K	838K	234K	116K	180K	3M
Total Non-Current Assets	3M	3.2M	2.3M	1.7M	1.9M	3.3M
Total Assets	806.9M	496.8M	368M	200.2M	92.4M	8.3M
LIABILITIES
CURRENT LIABILITIES
Total Payables	9M	7.9M	12.6M	16.2M	2.6M	2.4M
Accounts Payable	9M	7.9M	12.6M	16.2M	2.6M	2.4M
Accrued Expenses	0.0	8M	2.4M	2.5M	4.1M	5.8M
Short Term Debt	611K	0.0	0.0	0.0	5M	16.7M
Capital Lease Obligations (Current)	0.0	130K	665K	307K	319K	0.0
Tax Payables	0.0	0.0	0.0	0.0	0.0	100.3K
Other Current Liabilities	27M	7.2M	5.8M	3.6M	1.5M	0.0
Total Current Liabilities	36.6M	23.3M	21.4M	22.6M	13.4M	24.9M
NON-CURRENT LIABILITIES
Long Term Debt	1.3M	28.3M	0.0	0.0	404K	5M
Other Non-Current Liabilities	29.2M	0.0	0.0	0.0	141.5M	353K
Total Non-Current Liabilities	30.4M	29.9M	1.4M	1M	143.2M	5.3M
Capital Lease Obligations	0.0	1.7M	2.1M	1.3M	1.7M	0.0
Total Liabilities	67.1M	53.2M	22.9M	23.6M	156.6M	30.2M
SHAREHOLDERS' EQUITY
Common Stock	4K	3K	2K	2K	0.0	2K
Additional Paid-In Capital	1.2B	741.3M	533.8M	288.8M	1.2M	91M
Retained Earnings	-510.2M	-298M	-188.6M	-112.2M	-65.4M	-112.8M
Accumulated Other Comprehensive Income/Loss	965K	289K	0.0	0.0	0.0	0.0
Total Stockholders' Equity	739.8M	443.6M	345.1M	176.6M	-64.2M	-21.9M
Total Equity	739.8M	443.6M	345.1M	176.6M	-64.2M	-21.9M
SUMMARY
Total Liabilities & Equity	806.9M	496.8M	368M	200.2M	92.4M	8.3M
Total Investments	700M	297.4M	0.0	0.0	0.0	0.0
Total Debt	1.9M	30M	2.1M	1.3M	7.1M	21.6M
Net Debt	-89.3M	-162.4M	-358.3M	-193.3M	-81M	17.1M
Shares Outstanding	37,749,448	37,749,448	37,749,448	37,749,448	37,749,448	37,749,448

SEC Filings

IRON - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
10-Q 10-Q 2026 Q1 Q1	May 05, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 05, 2026	May 05, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 28, 2026	June 18, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 27, 2026	February 26, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 26, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 26, 2026	February 26, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 17, 2026	February 17, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 13, 2026	February 13, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 12, 2026	January 12, 2026	2026	View Filing
8-K 8-K 2025 N/A	December 08, 2025	December 07, 2025	2025	View Filing

Showing 1 to 10 of 136 filings

Related Guides

Blog Categories

Continue your IRON research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.